4.3 Article

Serum Ferritin as a Predictor of Outcomes in Hospitalized Patients with Covid-19 Pneumonia

Related references

Note: Only part of the references are listed.
Article Immunology

Ferritin level: A predictor of severity and mortality in hospitalized COVID-19 patients

Moudhi Alroomi et al.

Summary: This study investigated in-hospital mortality in severe acute respiratory syndrome coronavirus 2 patients stratified by serum ferritin levels. The results showed that higher levels of serum ferritin, along with hypertension and pneumonia, were associated with predicting in-hospital mortality. Patients with ferritin levels > 1000 had a higher mortality rate.

IMMUNITY INFLAMMATION AND DISEASE (2021)

Review Allergy

Risk factors for severe and critically ill COVID-19 patients: A review

Ya-dong Gao et al.

Summary: The severity factors of COVID-19 include age, gender, underlying health conditions such as hypertension, diabetes, obesity, and immunodeficiency, which may lead to complications like acute kidney injury. Various laboratory indicators and parameters can help monitor disease progression, while socioeconomic factors, lifestyle, and quality of healthcare also play a role in individual outcomes.

ALLERGY (2021)

Letter Medicine, General & Internal

Procalcitonin accurately predicts mortality but not bacterial infection in COVID-19 patients admitted to intensive care unit

Charlotte Vanhomwegen et al.

IRISH JOURNAL OF MEDICAL SCIENCE (2021)

Article Critical Care Medicine

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021

Laura Evans et al.

CRITICAL CARE MEDICINE (2021)

Article Gastroenterology & Hepatology

Abnormal ferritin levels predict development of poor outcomes in cirrhotic outpatients: a cohort study

David Tornai et al.

Summary: This study demonstrated the prognostic potential of serum ferritin in cirrhotic patients, showing that both low and high concentrations of ferritin need attention. Low ferritin concentration was associated with the development of decompensated clinical stage in previously compensated cirrhotic patients, while higher ferritin levels were linked to increased risks of bacterial infections in decompensated patients and mortality in the whole population.

BMC GASTROENTEROLOGY (2021)

Article Multidisciplinary Sciences

Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: data from two Italian COVID-19 units

Francesco Carubbi et al.

Summary: A total of 61 hospitalized patients in Italy were retrospectively evaluated to identify the relationship between ferritin levels and severity of pulmonary involvement in patients with COVID-19. The study found that ferritin levels above the 25th percentile were associated with more severe pulmonary involvement, independent of age and gender.

SCIENTIFIC REPORTS (2021)

Article Medicine, General & Internal

Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19 The HEP-COVID Randomized Clinical Trial

Alex C. Spyropoulos et al.

Summary: Therapeutic-dose low-molecular-weight heparin reduces major thromboembolism and death in high-risk inpatients with COVID-19, with no significant effect observed in critically ill patients.

JAMA INTERNAL MEDICINE (2021)

Review Pediatrics

Biomarkers in COVID-19: An Up-To-Date Review

Madhusudan Samprathi et al.

Summary: Biomarkers play a crucial role in the COVID-19 pandemic, providing important information for clinical diagnosis and treatment. Different categories of biomarkers offer valuable insights, but there is still a lack of definitive answers on which biomarkers to evaluate when and in whom, and how best to utilize this information.

FRONTIERS IN PEDIATRICS (2021)

Letter Medicine, General & Internal

Effectiveness of Tocilizumab in Patients Hospitalized With COVID-19 A Follow-up of the CORIMUNO-TOCI-1 Randomized Clinical Trial

Xavier Mariette et al.

Summary: This follow-up study explores the relationship between survival and C-reactive protein levels in patients hospitalized with COVID-19 who were treated with tocilizumab.

JAMA INTERNAL MEDICINE (2021)

Article Multidisciplinary Sciences

D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19

Ayusha Poudel et al.

Summary: This study found that admission D-dimer value is an accurate biomarker for predicting mortality in patients with COVID-19, with an optimal cutoff value of 1.5 mu g/ml.

PLOS ONE (2021)

Article Medicine, General & Internal

Prediction of Cytokine Storm and Mortality in Patients with COVID-19 Admitted to ICU: Do Markers Tell the Story?

Rashid Nadeem et al.

Summary: A study involving 235 patients with COVID-19 found that the average CRP level during ICU stay is the only factor predicting survival.

DUBAI MEDICAL JOURNAL (2021)

Article Medicine, General & Internal

Evaluation of serum ferritin for prediction of severity and mortality in COVID-19- A cross sectional study

Sibtain Ahmed et al.

Summary: This study found that serum ferritin concentration is a promising predictor of mortality in COVID-19 cases.

ANNALS OF MEDICINE AND SURGERY (2021)

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Article Medicine, General & Internal

Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

Tao Chen et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Article Hematology

D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19

Litao Zhang et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Letter Medicine, General & Internal

COVID-19: consider cytokine storm syndromes and immunosuppression

Puja Mehta et al.

LANCET (2020)

Article Hematology

Ferritin levels in patients with COVID-19: A poor predictor of mortality and hemophagocytic lymphohistiocytosis

Jonathan Feld et al.

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2020)

Review Public, Environmental & Occupational Health

Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis

Petek Eylul Taneri et al.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2020)

Review Medical Laboratory Technology

Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis

Linlin Cheng et al.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2020)

Article Respiratory System

C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis

Ian Huang et al.

THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2020)

Review Immunology

Hyperferritinemia and inflammation

Kate F. Kernan et al.

INTERNATIONAL IMMUNOLOGY (2017)

Article Immunology

Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia

Wesley H. Self et al.

CLINICAL INFECTIOUS DISEASES (2017)

Review Medicine, General & Internal

Effectiveness of D-Dimer as a Screening Test for Venous Thromboembolism: An Update

Swaroopa Pulivarthi et al.

NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES (2014)

Review Microbiology

Viral infection and iron metabolism

Hal Drakesmith et al.

NATURE REVIEWS MICROBIOLOGY (2008)